Current status of therapeutic monoclonal antibodies against SARS-CoV-2.

Bibliographic Details
Main Authors: Sanjeev Kumar, Anmol Chandele, Amit Sharma
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-09-01
Series:PLoS Pathogens
Online Access:https://doi.org/10.1371/journal.ppat.1009885
_version_ 1811304865928839168
author Sanjeev Kumar
Anmol Chandele
Amit Sharma
author_facet Sanjeev Kumar
Anmol Chandele
Amit Sharma
author_sort Sanjeev Kumar
collection DOAJ
first_indexed 2024-04-13T08:14:58Z
format Article
id doaj.art-995ce76e74ac4c58b2d6922168ff02af
institution Directory Open Access Journal
issn 1553-7366
1553-7374
language English
last_indexed 2024-04-13T08:14:58Z
publishDate 2021-09-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj.art-995ce76e74ac4c58b2d6922168ff02af2022-12-22T02:54:50ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742021-09-01179e100988510.1371/journal.ppat.1009885Current status of therapeutic monoclonal antibodies against SARS-CoV-2.Sanjeev KumarAnmol ChandeleAmit Sharmahttps://doi.org/10.1371/journal.ppat.1009885
spellingShingle Sanjeev Kumar
Anmol Chandele
Amit Sharma
Current status of therapeutic monoclonal antibodies against SARS-CoV-2.
PLoS Pathogens
title Current status of therapeutic monoclonal antibodies against SARS-CoV-2.
title_full Current status of therapeutic monoclonal antibodies against SARS-CoV-2.
title_fullStr Current status of therapeutic monoclonal antibodies against SARS-CoV-2.
title_full_unstemmed Current status of therapeutic monoclonal antibodies against SARS-CoV-2.
title_short Current status of therapeutic monoclonal antibodies against SARS-CoV-2.
title_sort current status of therapeutic monoclonal antibodies against sars cov 2
url https://doi.org/10.1371/journal.ppat.1009885
work_keys_str_mv AT sanjeevkumar currentstatusoftherapeuticmonoclonalantibodiesagainstsarscov2
AT anmolchandele currentstatusoftherapeuticmonoclonalantibodiesagainstsarscov2
AT amitsharma currentstatusoftherapeuticmonoclonalantibodiesagainstsarscov2